The earnings call reveals concerning financial metrics: increased operating loss, negative EBITDA, and a significant drop in cash balance. The backlog reduction and delayed revenue recovery, alongside supply issues, further compound the negative outlook. Management's vague responses about the wafer fab sale and short-term revenue recovery add uncertainty. Although optimistic guidance for future growth and new programs are noted, the immediate financial health and lack of clear short-term solutions suggest a negative sentiment.